Mount Sinai Health System: Combination Therapy Improves Outcomes for Advanced Triple-Negative Breast Cancer
August 22, 2025
August 22, 2025
NEW YORK, Aug. 22 (TNSjou) -- Mount Sinai Health System issued the following news release:
* * *
Combination Therapy Improves Outcomes for Advanced Triple-Negative Breast Cancer
New York, NY (August 21, 2025) - A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients with advanced triple-nega . . .
* * *
Combination Therapy Improves Outcomes for Advanced Triple-Negative Breast Cancer
New York, NY (August 21, 2025) - A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients with advanced triple-nega . . .